- Home
- IVVD vs HNST Comparison
IVVD vs HNST Comparison
Compare IVVD & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- HNST
- Stock Information
- Founded
- IVVD 2020
- HNST 2012
- Country
- IVVD United States
- HNST United States
- Employees
- IVVD N/A
- HNST N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- HNST Catalog/Specialty Distribution
- Sector
- IVVD Health Care
- HNST Consumer Discretionary
- Exchange
- IVVD Nasdaq
- HNST Nasdaq
- Market Cap
- IVVD 351.6M
- HNST 379.4M
- IPO Year
- IVVD 2021
- HNST 2021
- Fundamental
- Price
- IVVD $1.61
- HNST $3.36
- Analyst Decision
- IVVD Strong Buy
- HNST Buy
- Analyst Count
- IVVD 5
- HNST 5
- Target Price
- IVVD $6.11
- HNST $6.75
- AVG Volume (30 Days)
- IVVD 6.2M
- HNST 3.6M
- Earning Date
- IVVD 11-07-2025
- HNST 11-05-2025
- Dividend Yield
- IVVD N/A
- HNST N/A
- EPS Growth
- IVVD N/A
- HNST N/A
- EPS
- IVVD N/A
- HNST 0.06
- Revenue
- IVVD $46,210,000.00
- HNST $389,783,000.00
- Revenue This Year
- IVVD $102.11
- HNST $6.68
- Revenue Next Year
- IVVD $151.51
- HNST $4.81
- P/E Ratio
- IVVD N/A
- HNST $55.31
- Revenue Growth
- IVVD 1941.08
- HNST 9.58
- 52 Week Low
- IVVD $0.35
- HNST $3.29
- 52 Week High
- IVVD $2.74
- HNST $8.97
- Technical
- Relative Strength Index (RSI)
- IVVD 46.79
- HNST 34.44
- Support Level
- IVVD $1.74
- HNST $3.37
- Resistance Level
- IVVD $2.00
- HNST $3.71
- Average True Range (ATR)
- IVVD 0.24
- HNST 0.12
- MACD
- IVVD -0.06
- HNST -0.02
- Stochastic Oscillator
- IVVD 1.33
- HNST 13.79
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.